New hope for dialysis patients: drug combo may shield heart and kidneys
NCT ID NCT05498181
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tests whether a drug called sacubitril/valsartan can help people who just started hemodialysis. The goal is to see if it reduces fluid buildup in the heart and helps preserve any remaining kidney function. About 100 adults will receive either the drug or a placebo for 16 weeks. The trial is currently recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's
RECRUITINGBoston, Massachusetts, 02115, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.